Abstract
Background
Posttraumatic stress disorder (PTSD) can be perceived as a psychoneuroimmunological disorder in which cytokines affecting the neurochemical and neuroendocrine functions of the body play an important role. Among cytokines, chemokines participating in activation of the inflammatory response are considered to be crucial.
Method
220 men and women were enrolled in the study. 180 of them constituted the study group. The studied groups consisted of: 60 patients with a diagnosed avoidant personality disorders (APD), 60 patients with a diagnosed APD and with PTSD and of 60 patients with PTSD but without a APD. There were 30 women and 30 men in each group of 60 subjects. The control group consisted of 40 healthy individuals. The plasma levels of chemokines and their receptors (CCL-5, CXCR-5, CXCL-12 and CXCR-4), as well as IL-6, were assessed by ELISA.
Results
There was an increase in the CXCL-12 and CCL-5 levels in women and men with the PTSD versus the control group. Also, increased levels of IL-6 and the receptors CXCR-4, CCR-5 were observed in women and men with PTSD. The levels of CXCL-12 and CCL-5 chemokines, as well as CCR-5 and CXCR4 receptors were higher in women than in men. The results of this study indicate a need for assessment of the CCL-5 and CXCL-12 chemokine levels, as they are likely markers of PTSD.
Conclusions
Measurement of the concentrations of chemokines, chemokine receptors and IL-6 in women and men with PTSD along with concomittant APD may be useful for early detection of mental disorders.
Similar content being viewed by others
References
Ogłodek E, Araszkiewicz A. Post-traumatic stress. Pol Merkur Lekarski 2012;32(187):5–8.
Bauer ME, Wieck A, Lopes RP, Teixeira AL, Grassi-Oliveira R. Interplay between neuroimmunoendocrine systems during post-traumatic stress disorder: a mini review. Neuroimmunomodulation 2010;17(3):192–5.
Szota A, Oglodek E, Araszkiewicz A. A female patient with depression and conversion disorder following brain tumor surgery. Aust N Z J Psychiatry 2013;47(12):1213–4.
Angelucci F, Ricci V, Gelfo F, Martinotti G, Brunetti M, Sepede G, et al. BDNF serum levels in subjects developing or not post-traumatic stress disorder after trauma exposure. Brain Cogn 2014;84(1):118–22.
Monti JM, Cooke GE, Watson PD, Voss MW, Kramer AF, Cohen NJ. Relating hippocampus to relational memory processing across domains and delays. J Cogn Neurosci 2014;9:1–12.
Nair J, Singh Ajit S. The role of the glutamatergic system in posttraumatic stress disorder. CNS Spectr 2008;13(7):585–91.
Ogłodek E, Szota A, Just M, Moś D, Araszkiewicz A. The role of the neuroendocrine and immune systems in the pathogenesis of depression. Pharmacol Rep 2014;66(5):776–81.
Ogłodek EA, Szota A, Just MJ, Moś D, Araszkiewicz A. Comparison of chemokines (CCL-5 and SDF-1), chemokine receptors (CCR-5 and CXCR-4) and IL-6 levels in patients with different severities of depression. Pharmacol Rep 2014;66(5):920–6.
O’Sullivan JB, Ryan KM, Harkin A, Connor TJ. Noradrenaline reuptake inhibitors inhibit expression of chemokines IP-10 and RANTES and cell adhesion molecules VCAM-1 and ICAM-1 in the CNS following a systemic inflammatory challenge. J Neuroimmunol 2010;220(1–2):34–42.
Ogłodek EA, Szota AM, Just MJ, Moś DM, Araszkiewicz A. The MCP-1, CCL-5 and SDF-1 chemokines as pro-inflammatory markers in generalized anxiety disorder and personality disorders. Pharmacol Rep 2015;67(1):85–9.
Mommersteeg PM, Vermetten E, Kavelaars A, Geuze E, Heijnen CJ. Hostility is related to clusters of T-cell cytokines and chemokines in healthy men. Psychoneuroendocrinology 2008;33(8):1041–50.
Tripathi A, Davis JD, Staren DM, Volkman BF, Majetschak M. CXC chemokine receptor 4 signaling upon co-activation with stromal cell-derived factor-1α and ubiquitin. Cytokine 2014;65(2):121–5.
Newton TL, Fernandez-Botran R, Miller JJ, Burns VE. Interleukin-6 and soluble interleukin-6 receptor levels in posttraumatic stress disorder: associations with lifetime diagnostic status and psychological context. Biol Psychol 2014;99:150–9.
Gill JM, Saligan L, Lee H, Rotolo S, Szanton S. Women in recovery from PTSD have similar inflammation and quality of life as non-traumatized controls. J Psychosom Res 2013;74(4):301–6.
McCanlies EC, Araia SK, Joseph PN, Mnatsakanova A, Andrew ME, Burchfiel CM, et al. C-reactive protein, interleukin-6, and posttraumatic stress disorder symptomology in urban police officers. Cytokine 2011;55(1):74–8.
DiMauro J, Carter S, Folk JB, Kashdan TB. A historical review of trauma-related diagnoses to reconsider the heterogeneity of PTSD. J Anxiety Disord 2014;28(8):774–86.
Levin AP, Kleinman SB, Adler JS. DSM-5 and posttraumatic stress disorder.J Am Acad Psychiatry Law 2014;42(2):146–58.
Levy Yeyati E. Posttraumatic stress disorder: meaningful changes in DSM-5. Vertex 2014;25(113):68–72.
Kapfhammer HP. Trauma and stressor-related disorders: diagnostic conceptualization in DSM-5. Nervenarzt 2014;85(5):553–63.
Marshall GN, Schell TL, Miles JN. A multi-sample confirmatory factor analysis of PTSD symptoms: what exactly is wrong with the DSM-IV structure? Clin Psychol Rev 2013;33(1):54–66.
Spitzer C, Wibisono D, Terfehr K, Löwe B, Otte C, Wingenfeld K. C-reactive protein, pre- and postdexamethasone cortisol levels in post-traumatic stress disorder. Nord J Psychiatry 2014;68(5):296–9.
Warner CH, Warner CM, Appenzeller GN, Hoge CW. Identifying and managing posttraumatic stress disorder. Am Fam Physician 2013;88(12):827–34.
Zhou J, Nagarkatti P, Zhong Y, Ginsberg JP, Singh NP, Zhang J, et al. Dysregulation in microRNA expression is associated with alterations in immune functions in combat veterans with post-traumatic stress disorder. PLoS One 2014;9(4):e94075.
Gola H, Engler H, Sommershof A, Adenauer H, Kolassa S, Schedlowski M, et al. Posttraumatic stress disorder is associated with an enhanced spontaneous production of pro-inflammatory cytokines by peripheral blood mononuclear cells. BMC Psychiatry 2013;13:40.
van der Meulen AA, Biber K, Lukovac S, Balasubramaniyan V, den Dunnen WF, Boddeke HW, et al. The role of CXC chemokine ligand (CXCL)12-CXC chemokine receptor (CXCR)4 signalling in the migration of neural stem cells towards a brain tumour. Neuropathol Appl Neurobiol 2009;35(6): 579–591.
Sorce S, Myburgh R, Krause KH. The chemokine receptor CCR5 in the central nervous system. Prog Neurobiol 2011;93(2):297–311.
Wieck A, Grassi-Oliveira R, Hartmann do Prado C, Teixeira AL, Bauer ME. Neuroimmunoendocrine interactions in post-traumatic stress disorder: focus on long-term implications of childhood maltreatment. Neuroimmunomodulation 2014;21(2–3):145–51.
Wahbeh H, Oken BS. Salivary cortisol lower in posttraumatic stress disorder. J Trauma Stress 2013;26(2):241–8.
Bruenahl CA, Arck PC, Linden M. Limitation of pro- and anti-inflammatory cytokine analysis to discriminate biological stress effects in patients suffering from chronic psychological distress. Nord J Psychiatry 2013;67(3):191–6.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Ogłodek, E.A., Szota, A.M., Moś, D.M. et al. Serum concentrations of chemokines (CCL-5 and CXCL-12), chemokine receptors (CCR-5 and CXCR-4), and IL-6 in patients with posttraumatic stress disorder and avoidant personality disorder. Pharmacol. Rep 67, 1251–1258 (2015). https://doi.org/10.1016/j.pharep.2015.05.023
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1016/j.pharep.2015.05.023